Target intelligence / Profile preview

Seco-sativene sesquiterpenoids

Molecular classification
Sesquiterpenoid, Terpenoid, Natural product, Fungal metabolite
01

Overview

Seco-sativene sesquiterpenoids are a specialized class of C15 fungal secondary metabolites characterized by a cleaved (seco-) sativene carbon skeleton. They are primarily produced by filamentous fungi in the genera Bipolaris, Cochliobolus, and Drechslera, which are known phytopathogens. These molecules are synthesized through the cyclization of farnesyl pyrophosphate into a sativene intermediate, followed by oxidative ring cleavage mediated by cytochrome P450 enzymes. Biologically, seco-sativene sesquiterpenoids are significant for their phytotoxic properties, which assist fungi in colonizing host plants by inducing necrosis or inhibiting growth. Beyond their role in plant pathology, some derivatives have shown antimicrobial and cytotoxic activities in pharmacological screens, marking them as scaffolds of interest for natural product chemistry and potential pesticide development. However, they are not classified as therapeutic targets themselves, but rather as bioactive chemical entities produced by biological sources.

Other names
Seco-sativane sesquiterpenesBipolaris sesquiterpenoidsSativene-derived metabolites
02

Mechanism of action

As secondary metabolites, these compounds do not have a therapeutic mechanism of action on human targets; instead, they often act as phytotoxins that disrupt plant cell membranes or interfere with plant growth regulation during infection (e.g., via the inhibition of seed germination or induction of chlorosis).

03

Biological functions

PhytotoxicityAntimicrobial activityCytotoxicitySecondary metabolismFungal virulence factor
04

Disease associations

Plant fungal infectionBipolaris-related plant diseasesCrop necrosis
05

Safety considerations

PhytotoxicityPotential environmental toxicityGeneral cytotoxicity to mammalian cells at high concentrations

Beyond the preview

Go deeper on Seco-sativene sesquiterpenoids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seco-sativene sesquiterpenoids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call